Related references
Note: Only part of the references are listed.Outcome of Chinese patients with hepatitis B at 96 weeks after functional cure with IFN versus combination regimens
Calvin Q. Pan et al.
LIVER INTERNATIONAL (2021)
Peg-interferon alpha add-on Tenofovir disoproxil fumarate achieved more HBsAg loss in HBeAg-positive chronic hepatitis B naive patients
Jing Li et al.
JOURNAL OF VIRAL HEPATITIS (2021)
Peginterferon and Entecavir Combination Therapy Improves Outcome of Non-Early Response Hepatitis B e Antigen-Positive Patients
Lu Chen et al.
OPEN FORUM INFECTIOUS DISEASES (2020)
Hepatitis B surface antigen and hepatitis B core-related antigen kinetics after adding pegylated-interferon to nucleos(t)ids analogues in hepatitis B e antigen-negative patients
Teresa Broquetas et al.
WORLD JOURNAL OF HEPATOLOGY (2020)
cccDNA Maintenance in Chronic Hepatitis B - Targeting the Matrix of Viral Replication
Maura Dandri et al.
INFECTION AND DRUG RESISTANCE (2020)
Predictors of sustained functional cure in hepatitis B envelope antigen-negative patients achieving hepatitis B surface antigen seroclearance with interferon-alpha-based therapy
Ming-Hui Li et al.
JOURNAL OF VIRAL HEPATITIS (2019)
Therapeutic strategies for hepatitis B virus infection: towards a cure
Gregory C. Fanning et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
Kinetics of Hepatitis B Surface Antigen Level in Chronic Hepatitis B Patients who Achieved Hepatitis B Surface Antigen Loss during Pegylated Interferon Alpha-2a Treatment
Ming-Hui Li et al.
CHINESE MEDICAL JOURNAL (2017)
Sequential Combination Therapy with Pegylated Interferon Leads to Loss of Hepatitis B Surface Antigen and Hepatitis B e Antigen (HBeAg) Seroconversion in HBeAg-Positive Chronic Hepatitis B Patients Receiving Long-Term Entecavir Treatment
Guo-Jun Li et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Hepatitis B virus e antigen (HBeAg) may have a negative effect on dendritic cell generation
Ibrahim Hatipoglu et al.
IMMUNOBIOLOGY (2014)
Reduction of HBV replication prolongs the early immunological response to IFNα therapy
Anthony T. Tan et al.
JOURNAL OF HEPATOLOGY (2014)
Differential boosting of innate and adaptive antiviral responses during pegylated-interferon-alpha therapy of chronic hepatitis B
Lorenzo Micco et al.
JOURNAL OF HEPATOLOGY (2013)
In Vivo Proliferation of Hepadnavirus-Infected Hepatocytes Induces Loss of Covalently Closed Circular DNA in Mice
Marc Lutgehetmann et al.
HEPATOLOGY (2010)
Impaired function of hepatic natural killer cells from murine chronic HBsAg carriers
YY Chen et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2005)
Share Paper
